Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

LENSAR, Inc. - Common Stock (NQ:LNSR)

6.806 -3.454 (-33.66%)
Streaming Delayed Price Updated: 2:33 PM EDT, Mar 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

All News about LENSAR, Inc. - Common Stock

< Previous 1 2 3 4 Next >
News headline image
Lensar Stock Slumps After Hours On Ending Merger Deal With Alcon Over FTC Pushback ↗
Lensar said that its deal with Alcon is unlikely to receive necessary regulatory approvals in the U.S. by April 23 or even by July 23. 
Via Stocktwits
News headline image
Lensar (LNSR) Q2 Revenue Rises 10% ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LNSR, ATAI, ICAD on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SVT, LNSR, ICAD, SSBK on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
LENSAR - Top Healthcare Equipment Stock ↗
LENSAR, Inc., a commercial-stage medical device company. 
Via Talk Markets
Topics Stocks / Equities
News headline image
Earnings Scheduled For February 27, 2025 ↗
 
Via Benzinga
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LNSR, SWTX, ICAD, SSBK on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
LENSAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LENSAR, Inc. - LNSR
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LNSR, ICAD, BSGM, SSBK on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Alcon Secures First FDA Approval Since Novartis Spin-Off In 2019 ↗
FDA approves Alcon's Tryptyr for dry eye disease, backed by Phase 3 trials showing strong efficacy in increasing natural tear production. 
Via Benzinga
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Landsea Homes Corporation (Nasdaq - LSEA), LENSAR, Inc. (Nasdaq - LNSR), AvidXchange Holdings, Inc. (Nasdaq – AVDX), FARO Technologies, Inc. (Nasdaq – FARO)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DNB, LNSR, TASK on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LSEA, FARO, LNSR, AVDX on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Landsea Homes Corporation (Nasdaq - LSEA), LENSAR, Inc. (Nasdaq - LNSR), AvidXchange Holdings, Inc. (Nasdaq – AVDX), FARO Technologies, Inc. (Nasdaq – FARO)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FARO, AVDX, LNSR on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Hall of Fame Resort & Entertainment Company (Nasdaq – HOFV), LENSAR, Inc. (Nasdaq - LNSR), AvidXchange Holdings, Inc. (Nasdaq – AVDX), FARO Technologies, Inc. (Nasdaq
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LNSR, TURN, DNB, GB on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: LENSAR, Inc. (Nasdaq - LNSR), 180 Degree Capital Corp. (Nasdaq – TURN), Dun & Bradstreet Holdings, Inc. (NYSE - DNB), Global Blue Group Holding AG (Nasdaq - GB)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: LENSAR, Inc. (Nasdaq - LNSR), 180 Degree Capital Corp. (Nasdaq – TURN), Dun & Bradstreet Holdings, Inc. (NYSE - DNB), Global Blue Group Holding AG (NYSE - GB)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
LENSAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LENSAR, Inc. - LNSR
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AZEK, LNSR, DNB on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Alcon Eyes Surgical Edge With LENSAR Buyout: Details ↗
Alcon is set to acquire LENSAR Inc. in a $356 million deal. This acquisition includes LENSAR's advanced cataract laser technologies, boosting Alcon's offerings in femtosecond laser-assisted cataract... 
Via Benzinga
News headline image
Shareholder Alert: The Ademi Firm Investigates Whether LENSAR, Inc. is Obtaining a Fair Price for Its Public Shareholders
From Ademi & Fruchter LLP
Via Business Wire
News headline image
LNSR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of LENSAR, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
Alcon Agrees to Acquire LENSAR, Inc.
From Alcon Inc. Investors
Via Business Wire
News headline image
LENSAR Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update
31 ALLY Robotic Cataract Laser Systems™ placed in Q4 2024, representing an 86% increase in ALLY placements in full year 2024 over 2023; Company’s total installed systems increased to approximately 385... 
Via FinancialNewsMedia
News headline image
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From LENSAR, Inc.
Via Business Wire
News headline image
LENSAR to Participate in Two Upcoming Investor Conferences
From LENSAR, Inc.
Via Business Wire
News headline image
LNSR Stock Earnings: LENSAR Misses EPS, Beats Revenue for Q2 2024 ↗
LNSR stock results show that LENSAR missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
LENSAR Reports Second Quarter 2024 Results and Provides Business Update
From LENSAR, Inc.
Via Business Wire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.